@entity158 and urinary hesitancy in association with antidepressant therapy: relief with XXXX .

@entity6700 @entity1 @entity19584 @entity8991 @entity905 @entity5829 @entity18891 @entity2645 @entity158 @entity750 @entity906 @entity9940
@entity158 has been reported in association with a variety of antidepressants such as the tricyclic antidepressants (TCAs, e.g. @entity8991 , @entity2645 , @entity5829 , @entity6700 , @entity19584 ), the selective @entity750 reuptake inhibitors (SSRIs, e.g. @entity905 ), @entity906 and the MAOIs. Apart from lowering the dose and changing the antidepressant, no strategies are available to treat this side effect. In this paper, @entity158 following the administration of @entity18891 is described in two @entity1 . Both @entity1 were treated concomitantly with the selective alpha(1A)-adrenoceptor antagonist, @entity9940 . A re-challenge was performed in one @entity1 . The Hamilton Depression Rating Scale (HAM-D), the American Urological Association symptom index, a (dis)satisfaction item score and the Udvalg for Kliniske Undersoegelser (UKU-side effect rating scale) were used to assess the treatment. @entity9940 rapidly and completely resolved the @entity158 and urinary hesitancy in both @entity1 . A re-challenge in one @entity1 resulted in a prompt reappearance of both side effects. @entity9940 resolved the problem of @entity158 in these @entity1 ; however, larger studies are needed to confirm these results.
